A molecular brake on the activity of first-line immune cells could slow the progression of Parkinson’s disease. Prof. Gaëtan Garraux explains.
- Parkinson’s disease may be linked to a dysregulation of the immune system. Prof. Gaëtan Garraux and his team are investigating whether a drug already used to treat certain rare diseases could help regulate these cells and, ultimately, slow the progression of the disease.
